Introduction
Recent surges in heroin use have resulted in alarming spikes in overdoses. We report a surge in two adjacent counties within New Jersey known as the 'Jersey Shore' where heroin overdoses increased by 176% from February 2016 to March 2016. This region includes Monmouth and Ocean counties. Ocean county is located 50 miles east of Philadelphia, 70 miles south of New York City, and 25 miles north of Atlantic City and has a population of 592 497 with 33 municipalities. Monmouth County has a population of 625 846 with 53 municipalities and borders Ocean County to the north.
1-3

Background
The United States is experiencing an epidemic of drug overdose deaths. From 2000 to 2014, the rate of death from drug overdoses in the United States has increased 137%, including a 200% increase in the rate of overdose death involving opioids, including prescription pain relievers and heroin. 4 The Centers for Disease Control and Prevention (CDC) analyzed recent multiple cause-of-death mortality data to examine current trends and characteristics of drug overdose deaths including the types of opioids involved. During 2014, 47 055 drug overdose deaths occurred in the United States representing a 1-year increase of 6.5%, from 13.8 per 100 000 persons in 2013 to 14.7 per 100 000 persons in 2014. 4 The CDC recognizes New Jersey as having a significant increase in drug overdose death rates with a 16.4% increase from 2014 to 2015. 5 Nationally, from 2014
to 2015 there was a 20.6% increase in death rate due to heroin. 5 In May of 2013, New Jersey Governor, Chris Christie, signed the Overdose Protection Act into law. 6 The legislation outlines three paths to reduce opioid drug overdose deaths. First, it provides legal protection to those who are otherwise in violation of a law regarding controlled dangerous substances while they are attempting to help a drug overdose victim. Second, the law protects the overdose patient from prosecution for violation of a controlled dangerous substance law. Lastly, the act prohibits any legal action against health care professionals or bystanders who administer overdose antidotes in life-threatening situations.
Although paramedics in New Jersey have historically carried and used naloxone for opioid overdoses as part of their standard treatment protocols, since the law was enacted, many police and basic life support (BLS) agencies across New Jersey have acquired the necessary training and instituted protocols to administer intranasal (IN) naloxone in necessary circumstances. New Jersey's EMS system is designed to operate through three distinct tiers, as detailed in Fig. 1 
Methods
IRB approval was granted and a retrospective chart review was performed from 1 January 2016 to 15 April 2016 on the de-identified electronic medical records (EMRs) of patients who received naloxone, using 'naloxone' or 'Narcan' as the query term in the chart search (Rescue Net ID, Smithtown, IL) in Monmouth or Ocean counties in order to determine the number of naloxone administrations by different providers, evaluate demographics of patients, and to extrapolate the number of heroin overdoses. Rescue Net is utilized by this EMS system that transports patients to 43 hospitals in the state, five of which are in Monmouth County and four in Ocean County. Two researchers independently abstracted data to assure reliability. Inclusion criteria were the terms 'naloxone' or 'Narcan' in EMRs from the dates above. The only exclusion criteria was a canceled call, in which a chart was created in error. Data abstracted from each chart included the following: date of service, gender, age, nature of call, lowest level of consciousness based on the AVPU scale (alert, responds to verbal stimuli, responds to painful stimuli or unresponsive), overall change in clinical status, and status on arrival to the hospital. Narratives were reviewed and screened for signs of obvious narcotic use, such as the presence of drug paraphernalia or patients' admission to opioid use. Clinical improvement was defined as an improvement in mental status based on the AVPU scale and/or improvement in or normalization of vital signs when available. Means and interquartile ranges were calculated using Microsoft Excel (version 15.0; Microsoft, Redmond, WA).
Results
A total of 314 charts were reviewed; 312 were included and 2 were excluded due to ALS cancellation. Of the 312 patients, 233 patients (74.7%) were 'unresponsive' or had altered mental status which improved with naloxone.
Of all naloxone recipients, 216 (69.2%) were male. Ages ranged from 15 to 102 with a mean age of 39.6 and interquartile range (IQR) of 27-49 (Fig. 2) . In 207 (66.3%) charts, some form of substance use was documented by paramedics reported as 'drug paraphernalia', 'visible track marks', 'wax paper' consistent with heroin packaging, patient or bystander confirming heroin use, or reported use of methadone, suboxone or other prescription opioids. In total, 105 (33.7%) chart narratives did not give any specific information regarding findings on scene or discrete evidence of drug use (Table 1 ).
In total, 212 patients received a first dose of naloxone by a police officer or by a BLS provider prior to ALS arrival; 1 patient received naloxone by a family member; 99 patients received a first dose of naloxone by an ALS provider. Of these 213 patients who received naloxone prior to ALS arrival, 50 (23%) received an additional dose of naloxone by paramedics. The 57 of 213 patients (26.7%) received naloxone by more than one provider prior to ALS administration, sometimes by both police and BLS. Of these patients who first received naloxone prior to ALS arrival, 190 (89.2%) improved; 202 (94.8%) arrived to the hospital alive and 11 (5.2%) were pronounced dead.
Of the patients who received a first naloxone dose by ALS providers, 41 patients (41.4%) demonstrated obvious signs of heroin or narcotic use. Despite police or BLS first on scene, in 33 (33.3%) cases no naloxone was administered prior to ALS administration. In total, 43 (43.4%) of these patients improved; 80 (80.8%) arrived to the hospital alive and 19 (19.3%) were pronounced dead.
In all patients, 233 (74.7%) demonstrated clinical improvement as either an improved mental status, increased respiratory rate (as noted in chart narratives), or improved vital signs; 282 (90.4%) patients arrived alive to an emergency department and 30 (9.6%) were pronounced dead.
When analyzing data by dates, 48 patients received naloxone in January, 58 in February, 160 in March and 46 in the first 2 weeks of April (Fig. 3 ). Of note, 27 patients received pre-hospital naloxone during the 4-day period from Thursday, 17 March 2016 to Sunday, 20 March 2016, in this two-county EMS territory. Overall, 15 patients received prehospital naloxone on Saturday, 19 March 2016 alone.
Statistics on Glasgow Coma Scale scores, vital signs, including respiratory rates and pulse oximetry measurements, could not be calculated because of lacking data on patients who received naloxone from police or BLS prior to ALS involvement.
Discussion
The CDC has declared an epidemic of drug overdose deaths in the United States with a drastic increase in illicit drug death due to heroin. Heroin overdose death rates have more than tripled from 2010 to 2014, from 1.0 per 100 000 to 3.4 per 100 000. 3 The relatively low price, increased availability, and enhanced purity of heroin contribute to the surge of its use and subsequent overdoses. 7, 8, 9 Reports in New Jersey show a 660% increase in submissions for lab analysis from law enforcement seizures from the first to fourth quarter in 2015 with a 2000% increase in glassine bag (clear plastic packaging) submissions for testing. 10 While the national average of heroin purity is 26%, the average purity in some parts of New Jersey is 56%. 10 Adulterated heroin is becoming a major public health concern. Nationally, the CDC reports a 72.2% increase in death rates from 2014 to 2015 from synthetic opioid overdoses. 5 Seventy two percent of adulterated heroin seized in New Jersey was mixed with some form of fentanyl. 10 Ocean Oxycodone was the most common pill submitted for lab testing after seizure in 201 5 10 and the recognized association of prescription opioid addiction and elicit drug overdoses has been established. 12 While the data extracted from the EMR yields quantifiable statistics, the narratives charted by paramedics yield some valuable qualifying data, particularly regarding evidence of heroin or opiate use. Patients were routinely found with needles in their arms, unconscious and unresponsive. Many charts indicate the number of bags of heroin used, as reported by the patient upon regaining consciousness. Two OPIOID CRISIS AT THE JERSEY SHORE e115 to three bags used just prior to overdose were commonplace with six bags as the highest number documented. The youngest patients, aged 15 and 17, were reported as polysubstance uses with 'lean', anecdotally described as a combination of prescription codeine/promethazine cough syrup mixed with a soft drink, and 'Z bars [combined] with sniffing percocet', or a tablet of alprazolam, often 2 mg, as either self-disclosed or reported by family. The oldest patients in which naloxone was effective report being on a prescription narcotic. In contrast to the meta-analysis by Giglio et al. 13 where 39 of 66 witnessed overdose events had successful recovery by lay participant administration of naloxone, only one patient received naloxone, 2 mg IN, by a family member. A police officer administered an additional 2 mg intranasal naloxone after arriving first on scene and began CPR. Although CPR was continued en route, the patient did not survive.
Chart narratives are completely provider dependent and our agency has no formal policy on the detail required. Some paramedics use this section to chronologically describe a patient encounter in great detail while others type a generalized statement-'Vital signs as noted in chart. Transfer of care to RN'. Nearly 90% of patients clinically improved when they received a first dose of naloxone by a police officer or a BLS provider. Although only 79% of these patients have opioid use documented in chart narratives, given the inconsistent documentation of details, the authors extrapolate that nearly 90% of these patients actually had an opioid intoxication.
Of the patients who received a first dose of naloxone by ALS, one-third had a first responder capable of administering naloxone on scene first with documentation of obvious heroin and/or opioid use. Per narratives, 25 of these patients had used heroin and 8 had used some opioid pill. All patients clinically improved demonstrating that, despite the recognition of heroin and/or other opioid use by trained providers, opioid reversal treatment should have been initiated. Future studies should aim to evaluate this disconnect.
In regards to this same subset, mortality was higher with less clinic clinical improvement. The average age of patients receiving naloxone by first responders was 34.3. Obvious narcotic use was found in 79.3% with 89.2% clinical improvement and 9.6% mortality. The average age of patients receiving a first dose of naloxone by ALS providers was 50.9. Of these, 41% had documented narcotic use with 43.4% clinical improvement and 19.3% mortality. Perhaps first responders had an easier time recognizing opioid use in these younger patients and perhaps naloxone was given to older patients who may have presented with a mixed, or vague, clinical presentation. Unconsciousness may have been due to a myriad of other conditions and given the awareness of the current state of opioid toxicity, some medical control physicians order the medics to administer naloxone as a 'last ditch' therapy, even if a patient is already in cardiac arrest. Additionally we cannot prove or disprove that a missedchance of naloxone administration by these first responders impacted clinical outcomes. It is unknown if autopsies and toxicologic studies were performed on all patients, although it is not likely. The authors were not able to cross reference all cases with the medical examiners' offices and cannot definitively determine whether a lack of response to naloxone was due to fentanyl or another adulterant.
Our study has several limitations. First, given our data was obtained from paramedic charts, there was no opportunity for real-time toxicology results, nor were the authors able to obtain post mortem toxicology reports on all patients. A second limitation is that our data underreports the actual number of heroin overdoses in Monmouth and Ocean counties. Patients still receive naloxone by police without EMS involvement and reports indicate 253 patients were given naloxone in the two-county system from January through March 2016 by police officers. Some of these patients are included in our data, when recorded, however the number of cases of police administered naloxone are higher than our data when EMS was present with police indicating that naloxone was administered more times than described in our data. Additionally not reported was the number of individuals found dead with the medical examiner called directly by police, therefore having no ALS involvement. Another limitation is our lack of patient follow-up. This agency's EMR is utilized by our entire pre-hospital EMS system although not by any receiving hospitals therefore ongoing patient status and ultimate disposition is unknown beyond arrival to the emergency departments.
We have identified two adjacent counties in central New Jersey known as the 'Jersey Shore' where the overdose rate and subsequent use of naloxone has increased by 176% from 1 February 2016 to 31 March 2016. Although several strategies have been implemented locally and nationally to attempt to reduce the abuse of and overdoses from opioids including limiting prescribing in acute pain, providing unused and expired medication drop-boxes, expanding prescription monitoring programs, and increasing drug seizures, the future of the Jersey Shore's opioid crisis has yet to be determined.
